EUVIMEDEUVIMED entdecken
Crossref

Hplc Method Development and Validation of Iguratimod Tablet Dosage Form

Kulwinder Singh, Akshi Sharma, Nirmal singh, Ekta wadhera

International Journal of Drug Delivery Technology · 06.08.2026 · 16 (72s)

DOI: 10.25258/ijddt.16.72s.3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 06.08.2026. Verfasst von Kulwinder Singh und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

.

Zitieren

APA

Singh, K., Sharma, A., singh, N., & wadhera, E. (2026). Hplc Method Development and Validation of Iguratimod Tablet Dosage Form. International Journal of Drug Delivery Technology, 16(72s). https://doi.org/10.25258/ijddt.16.72s.3

Vancouver

Singh K, Sharma A, singh N, wadhera E. Hplc Method Development and Validation of Iguratimod Tablet Dosage Form. International Journal of Drug Delivery Technology. 2026;16(72s). doi:10.25258/ijddt.16.72s.3

BibTeX
@article{Singh2026,
  author = {Singh, Kulwinder and Sharma, Akshi and singh, Nirmal and wadhera, Ekta},
  title = {Hplc Method Development and Validation of Iguratimod Tablet Dosage Form},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {72s},
  doi = {10.25258/ijddt.16.72s.3}
}
Kostenlos starten →